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Effect of stage duration on physiological variables commonly used to determine maximal 
aerobic performance during cycle ergometry. 
 
Running Head: Effect of stage duration on variables associated with aerobic performance  
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ABSTRACT 
 
The current study investigated the effect of stage duration on physiological variables commonly 
used to determine maximal aerobic performance during cycle ergometry.   
Ten recreationally trained males (age: 27.8 ± 7.1 yrs; BMI: 24.3 ± 2.5 kg·m-2; &VO2max: 52.5 ± 
5.9 ml·kg-1·min-1) performed three different stage duration protocols on two separate occasions.  
Every Short Stage - SS (1-min stages), Long Stage - LS (3-min stages) and Constant Load + 
Short Stage - CL+SS (4-min constant load followed by 1-min stages) protocol started at 50W 
with 30W increases.  Physiological variables measured included: time to maximum, Wmax, 
&VO2max, HRmax, RPEmax, BLamax and RERmax.  Ventilatory threshold (VT) was calculated 
for every trial of the three protocols. 
There was no difference in &VO2max, but HRmax was higher in the LS protocol (P<0.05). 
RERmax varied between the protocols (P<0.05), while Wmax differed between the SS and LS 
protocols, and the LS and CL+SS protocols (P<0.0001).  Physiological variables were 
comparable between trials for the SS and CL+SS protocols, but Wmax and &VO2max differed 
for the LS protocol (P<0.05).  Workload at VT was lower for the LS protocol (P<0.05).  HR at 
VT was different between the LS and CL+SS protocols (P<0.05).   
Performing a test involving 1- or 3-min stage durations on a singular occasion was appropriate 
for &VO2max and VT determination.  However, the disparity in heart rate and workload could 
result in differences in mechanical and physiological work being undertaken.  Consistent use of 
a protocol may alleviate errors during exercise prescription. 
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INTRODUCTION 
 
The maximal rate of oxygen consumption ( &VO2max) attained during an incremental graded 
exercise test has long been used to predict endurance performance (Bentley et al., 2003; Kuipers 
et al., 2003).  While the aerobic power of an individual ultimately influences the &VO2max 
endpoint, the determination process can also have a significant bearing upon the final results.  A 
combination of multiple mechanical workloads at steady state with the measurement of 
&VO2max is optimal for obtaining the maximum amount of data from the one test.  However, the 
incorporation of both of these elements into the one test will most likely result in a test duration 
exceeding 12 mins.  The problem that arises is that numerous authors suggest tests for &VO2max 
should last between 8-12 mins as prolonged tests may produce inconsistent results (Thoden, 
1991; Wasserman et al., 1994).     
 
The impact of varying the length of stage duration, and hence the overall duration of a graded 
exercise test, has been evaluated previously in untrained individuals.  Buchfuhrer et al. (1983) 
indicated &VO2max was significantly higher when the stage duration was of sufficient length to 
induce a test time ranging from 8-17 mins.  Both McLellan (1985) and Froelicher et al. (1974) 
reported similar findings, with higher &VO2max values recorded when using stage durations of 
less than 60 secs.  In contrast, a study by Zhang et al. (1991) found no significant difference in 
&VO2max or anaerobic threshold (AT) between four graded exercise tests with stage durations 
ranging from 1 to 3 mins.  Studies to assess &VO2 or workload at ventilatory threshold (VT) have 
also provided conflicting reports regarding the impact of different graded exercise protocols 
(McLellan, 1985; Prioux et al., 1997; Yoshida, 1984).   
 
A number of studies with similar protocol comparisons to McLellan (1985) and Froelicher et al. 
(1974) have also assessed the impact of long and short stage durations on &VO2max in 
recreational and elite-trained populations using a variety of exercise modalities.  For example, 
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Bishop et al. (1998) showed a 3-min compared to 1-min stage incremental cycling protocol 
could be used without compromising &VO2max in eight moderately-active females.  Pierce et al. 
(1999) assessed aerobic parameters in eleven highly-trained rowers, concluding that 
discontinuous protocols involving seven stages of 3-4 mins duration (total test time of 21-28 
mins) can provide &VO2max measurements similar to those that averaged 12 mins ± 4 secs 
duration.  In a comparable study conducted on eight well-trained runners, Kuipers et al. (2003) 
found that mean &VO2max was not significantly different between three protocols conducted 
with 1-, 3- and 6-min stage durations.   
 
Importantly, the majority of studies reviewed provided no information regarding the 
achievement of a plateau in &VO2, or whether secondary criteria of blood lactate (BLa), 
respiratory exchange ratio (RER) or rating of perceived exertion (RPE) met threshold values 
used to define maximal effort.  Similarly, few of the studies compared aerobic variables at VT 
or AT between different protocols.  These shortcomings contribute to uncertainty as to the 
attainment of maximal aerobic power at the end of each test, and limit the number of 
comparative analyses that can be made between protocols.  Accordingly, an increase in the 
number of physiological parameters measured is likely to result in greater confidence 
concerning the impact of varying stage durations on &VO2max and other aerobic variables.   
 
A further component relating to &VO2max testing of relevance is the minimum number of tests 
required to obtain data of greatest suitability to the activity context.  For example, many 
endurance athletes undertake numerous &VO2max tests over the course of a season ostensibly to 
better monitor performance training load relationships.  As highlighted by Pierce et al. (1999), 
the completion of the minimum number of tests to be confident of the validity of data would 
reduce disturbances to training and decrease labour intensive testing and analysis.  Similarly, in 
a clinical setting, the performance of one &VO2max test in the knowledge that data was 
representative of cardiorespiratory function would also be valuable when time is at a premium 
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and only one test can be administered.  Consequently, the assessment of the repeatability of 
results from graded exercise tests is important to ensure data is consistent and comparable 
across trials.    
 
Following the establishment of the stage duration and test protocol that contributes to the 
procurement of the highest and most repeatable &VO2max value, utilisation of the data is 
important.  &VO2max has gained importance as a health-related physical characteristic used to 
predict all cause morbidity and mortality (Howley et al., 1995).  For that reason, the 
measurement or prediction of &VO2max plays an integral role in the way exercise is prescribed 
to sedentary and clinical populations.  Exercise intensity is most commonly referenced to the 
&VO2max of an individual, yet exercise prescription is generally defined as the mechanical 
workload (W) or heart rate (HR) at which a certain percentage of &VO2max occurs.  Previous 
research has found that the type of protocol used, and in particular the length of stage duration 
within a graded exercise test, can result in different values for maximum work performed 
(Wmax) and maximum HR achieved (HRmax) (Bishop et al., 1998; Wasserman et al., 1994).  
Subsequently, there is confusion regarding the HR or mechanical workload needed to achieve 
the desired percentage of &VO2max.  An assessment of the impact of short versus long stage 
durations on physiological variables during maximal aerobic performance will inform the 
prescription of exercise intensity. 
 
The purpose of this current study was to investigate the effect of stage duration on &VO2max, 
HRmax, Wmax and other physiological variables commonly used to determine maximal aerobic 
performance during cycle ergometry.  A subsequent aim of this study was to determine the 
repeatability of three graded exercise protocols performed on two separate occasions.  Finally, 
results from comparative analyses were used to delineate the influence of stage duration on the 
mechanical-physiological work relationship and subsequent potential impact on exercise 
prescription parameters. 
  
 
6
MATERIALS AND METHODS 
 
Participants 
 
Ten healthy adult males participated in the study.  Eligibility was dependent on individuals 
being euthyroid, non-diabetic, ambulatory, weight stable for at least six months (± 2 kg), and 
recreationally trained.  Recreationally trained was defined as completing regular bouts of 
exercise (30 mins or more, three times per week) in a non-competitive setting for at least 12 
months prior to recruitment.  Respondents were ineligible if they were taking medication known 
to affect HR or body composition.  Descriptive characteristics of the participants are presented 
in Table 1.  The study protocol was approved by the Human Research Ethics Committee at the 
Queensland University of Technology.  Written informed consent was obtained from each 
participant. 
 
Experimental design 
 
Three graded cycle ergometry protocols of different stage durations were performed in a 
random order.  Each protocol was then completed a second time in the same order each 
participant was tested previously.  One graded cycle ergometry protocol was completed every 
four days with three rest days in-between over a 4-week period (six tests in total).   
 
Height, body mass and resting HR were measured as baseline variables prior to testing.  Height 
was measured without shoes to the nearest 0.5 cm with a stadiometer.  Body mass was 
measured to the nearest 0.1 kg on a digital scale.  BMI was calculated from height and body 
mass values (body mass [kg] / height [m]2).  Resting HR, measured using a Polar Coded 
Transmitter and receiver (Polar Electro Oy, Kempele, Finland), was determined as the lowest 
averaged 30 sec value during the final 10 mins of a 30 min resting metabolic rate analysis.   
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Participants reported to the air-conditioned University laboratory for each of the six testing 
sessions at approximately the same time of day, and a minimum of four hours after their last 
food or fluid intake.  Instructions were given to wear lightweight, comfortable clothing, to 
abstain from strenuous exercise and consumption of caffeine, alcohol and salty foods in the 
previous 24 hours, and have voided a maximum of 10 mins before the test.  Prior to testing, 
participants were familiarised with the Borg 6-20 RPE scale (Borg, 1982), and were fitted with 
a Hans Rudolph mouthpiece (complete with two-way breathing valve) and a nose clip.  A Polar 
Coded Transmitter and receiver were also fitted to record HR every 5 secs throughout the test. 
 
All graded cycle ergometry protocols were performed on an electromagnetically-braked cycle 
ergometer (Excalibur Sport, Lode, Groningen, Netherlands).  Participants completed a 3-min 
warm up at 50W at a self-selected cadence.  After the warm-up, each protocol commenced with 
a starting workload of 50W followed by 30W incremental workload increases.  Although the 
ergometer had the capability for ramping the workload up by a constant resistance each second, 
workload was increased incrementally in a step-wise fashion at the completion of each stage.  
Therefore, the difference between the three protocols was the stage duration time; defined as the 
time spent at each workload before the next incremental workload increase.  The three different 
stage duration protocols were: 1-min stage durations (Short Stage - SS), 3-min stage durations 
(Long Stage - LS) or 4-min constant load first stage followed by 1-min stage durations 
(Constant Load + Short Stage - CL+SS).  The SS and LS protocols were developed specifically 
to assess the influence of different stage duration lengths upon maximal aerobic performance, 
while the CL+SS protocol was included to explore whether a prior constant load effort designed 
to examine exercise efficiency would impact upon end-point physiological responses.  During 
each trial, participants pedalled at a preferred cadence between 70 and 120 rpm and were 
instructed to keep the rpm constant throughout.  Workload was continually increased in 
accordance with stage duration parameters until physical exhaustion or when pedal cadence 
dropped below 40 rpm.     
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The following five threshold criteria were used to determine maximal aerobic performance: 1) 
plateau in VO2, 2) HR ±10 beats per min of age-predicted maximum, 3) volitional fatigue as 
determined by an RPE >18, 4) RER ≥ 1.10, and 5) BLa ≥8 mmol·-1.  VO2 plateau threshold was 
determined as a levelling off of oxygen uptake characterised by an increase of less than 2.5 
ml·kg-1·min-1 (Taylor et al., 1955) between the last two consecutive workload increases.  The 
HR used for the determination of HR threshold criteria was identified as the highest averaged 30 
sec value during the last completed workload stage.  The highest RPE value taken from the final 
15 secs of each workload and at the culmination of the test was used as the RPE threshold 
indicator of maximal physical exhaustion.  The RER used for the determination of RER 
threshold criteria was identified as the highest averaged 30 sec value during the last completed 
workload stage.  Finger-tip BLa samples taken in duplicate within 30 secs of finishing each 
graded cycle ergometry test were analysed via an ultraviolet endpoint method using the 
spectrophotometric assay procedure (Fink et al., 1990).  The mean of the duplicate samples was 
later used as the lactate threshold value.  The average CV of duplicate samples across all 
participants was 5.1%.  
 
Equipment 
 
During each graded cycle ergometry protocol, respiratory gases were collected as 5 sec samples 
using a MOXUS Modular VO2 System (AEI Technologies, Pennsylvania, USA).  A turbine 
attached to the inspired side of the Hans Rudolph mouthpiece measured airflow and volume, 
and it was verified before each measurement using a 3-Litre calibration syringe.  Verification 
was achieved when measured stroke volume at 60 L·min-1, 90 L·min-1 and 120·L min-1 was 
within ± 1.5% of syringe volume.  Oxygen concentration of expiration was measured via an S-
3A Oxygen Analyser sensor with a stabilised zirconia high-temperature electrochemical cell 
which has an inherently rapid response to changes in oxygen concentrations from 0-100%.  
Carbon dioxide concentration of expiration was measured using a CD-3A Carbon Dioxide 
Analyser which contains infrared optics with filters, a chopper and a cooled lead selenide 
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detector with preamplifier capable of continuous and accurate analysis of carbon dioxide 
concentrations from 0-15%.  A Model R-1 Flow Control that contains a flow meter, pump and 
needle valve was responsible for drawing the sample gases through the sensors and then venting 
them to the room.  Oxygen and carbon dioxide gas analysers were calibrated before each 
measurement using known standard gas concentrations (4.03% CO2, 15.10% O2).  Calibration 
was complete when gas analysers measured oxygen and carbon dioxide concentrations within 
±0.2% and ±0.08% of expected values, respectively.  The MOXUS Modular VO2 system was 
connected to an IBM-compatible personal computer for management and storage of data using 
the MAX II Metabolic System software (version 1.2.14, Physio-Dyne Instruments Corp.).   
 
Data management  
 
The three protocols will be addressed from this point onwards as the SS protocol (Short Stage 
protocol), the LS protocol (Long Stage protocol) and the CL+SS protocol (Constant Load + 
Short Stage) in line with the abovementioned descriptions. 
 
First presentation of each graded cycle ergometry protocols is referred to as trial 1.  The repeat 
presentation of the three protocols is referred to as trial 2.  Order effects could be excluded 
because four participants commenced with SS, three commenced with LS and three commenced 
with CL+SS. 
 
Time to maximum was recorded as the final completed min of stage duration time or a final 
fully completed min plus the last 30 sec block of the next uncompleted stage.  Oxygen 
consumption ( &VO2), carbon dioxide production ( &VCO2), respiratory exchange ratio (RER) and 
HR were collected every 5 secs and subsequently averaged over 30 secs.  The highest averaged 
30 sec value during the last completed work stage was recorded as the maximum value for 
&VO2max, RERmax and HRmax.  The maximum workload (Wmax) achieved was calculated 
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from the last completed work rate, plus any 30 sec block of time spent in the final non-
completed work rate multiplied by the work rate increment.  Maximum blood lactate (BLamax) 
was defined as the mean lactate reading taken from duplicate samples at the end of each trial.  
The final RPE reading taken during the last completed stage of the test was categorised as 
RPEmax. 
  
Ventilatory threshold (VT) was calculated using the ventilatory equivalent method as outlined 
in Gaskill et al. (2001).  Time, workload, &VO2, &VCO2, RER and HR were manually determined 
by identifying the corresponding values at the point of VT for each protocol trial performed.  
The % &VO2max value was calculated by dividing the relative &VO2 at VT into the &VO2max 
value from the same trial.   
 
Statistical analysis 
 
Data are presented as mean values and standard deviations (SD).  Unless otherwise stated, 
results from trial 1 and trial 2 for the 10 participants were combined (averaged) for data analysis 
purposes.  One-way repeated measures ANOVA was used to analyse for differences between 
the numbers of threshold criteria attained for the SS, LS and CL+SS protocols.  Paired sample t-
tests were used to determine the differences in time to maximum, &VO2max, HRmax, Wmax, 
RER, RPE, and BLamax between trial 1 and trial 2 for each protocol.  Pearson product-moment 
correlation coefficients and Bland-Altman (Bland et al., 1986) statistics were used to describe 
the relationship between these same variables in trial 1 and trial 2 for the SS, LS and CL+SS 
protocols.  The relationship between Wmax and &VO2max was also assessed using a Pearson 
product-moment correlation.  One-way repeated measures ANOVA was used to test the 
significance of differences between combined mean values (from trial 1 and trial 2) for time to 
maximum, &VO2max, HRmax, Wmax, RER, RPE, and BLamax in the SS, LS and CL+SS 
protocols.  The significance of differences in work, time, &VO2, &VCO2, RER, HR and 
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% &VO2max at the point of VT for the SS, LS and CL+SS protocols was also assessed via one-
way repeated measures ANOVA.  The Microsoft Excel program (version 10.4, 2002, Microsoft 
Corporation, Seattle, WA, USA) was used to compile the database and perform Bland-Altman 
plotting.  Statistical analyses were carried out with SPSS for Windows (version 13.0.1, 2004, 
SPSS, Chicago, IL, USA).      
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RESULTS 
 
As demonstrated in Table 2, the majority of physiological variables for the three protocols were 
positively and significantly correlated between trial 1 and trial 2, except for RERmax and 
RPEmax in the CL+SS protocol, and RPEmax and BLamax in the SS protocol.  In addition, 
Bland-Altman statistics provided in Table 3 indicate that negligible systematic variations in bias 
towards higher end-point physiological variables were evident in trial 2 for the SS protocol and 
in trial 1 for the LS and CL+SS protocols.  A narrow range in the limits of agreement for all 
physiological variables was evident for each protocol.   
 
No significant difference in physiological variables was evident between trial 1 and trial 2 for 
the SS and CL+SS protocols, demonstrating that these two protocols produced repeatable 
outcomes.  However, results shown in Table 4 indicate that there were significant differences in 
time to maximum, Wmax and absolute and relative &VO2max between trial 1 and trial 2 for the 
LS protocol.  HRmax, RERmax and BLamax reported for the LS protocol were not significantly 
different between trials.   
 
Comparisons of mean physiological variables for the SS, LS and CL+SS protocols are shown in 
Table 5.  HRmax was significantly higher in the LS protocol compared to SS and CL+SS 
protocols, but there was no significant difference in &VO2max, BLamax and RPEmax.  Time to 
maximum and RERmax was significantly different between all protocols, while Wmax was 
significantly different between the SS and LS protocols, and the LS and CL+SS protocols.  
&VO2max was significantly correlated to Wmax for the SS protocol (r = 0.58, P = 0.008) and the 
CL+SS protocol (r = 0.61, P = 0.005), but not for the LS protocol (r = 0.38, P = .095).  The 
relationship between mechanical and physiological work at &VO2max for the three protocols is 
illustrated in Figure 1.  The divergence in trendlines demonstrates that at similar &VO2max 
values, the LS protocol produced on average a lower Wmax compared to the SS and CL+SS 
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protocols.  Mean values for the highest HR and &VO2 responses at each individual workload 
stage from all 10 participants for the SS, LS and CL+SS protocols are shown in Figures 2 and 3 
respectively.      
 
The mean number of threshold criteria attained was not significantly different between the three 
protocols (SS: 3.4 ± 0.5; LS: 3.2 ± 0.8; CL+SS: 3.45 ± 0.5).  There was no significant difference 
in the number of &VO2 plateaus reached, with only 40%, 35% and 45% of trials successfully 
achieving the necessary threshold criteria in the SS, LS and CL+SS protocols respectively.  
Moreover, no significant difference was evident in the number of HR, RER, BLa and RPE 
threshold criteria attained between protocols.  Similarly, there was no significant difference in 
the number of &VO2 plateau and HR, RER, BLa and RPE threshold criteria met between trial 1 
and trial 2 for the SS, LS and CL+SS protocols.        
 
The point at which VT occurred was not significantly different between the SS, LS and CL+SS 
protocols, happening at 77.17 ± 7.21%, 75.34 ± 6.90% and 76.10 ± 7.35% of &VO2max  
respectively.  The workload at VT was significantly lower for the LS protocol compared to the 
SS (P<0.001) and CL+SS protocols (P<0.05), whereas the time at which VT occurred was 
significantly different between all three protocols (P<0.0001).  Also, HR at VT was 
significantly different between the LS and CL+SS protocols (P<0.05).  All other mean aerobic 
variables were not significantly different.   
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DISCUSSION 
 
The current study demonstrated that &VO2max was not affected by length of stage duration in 
incremental graded exercise cycling protocols.  This finding is consistent with previous reports 
by Bishop et al. (1998) and Zhang et al. (1991), who employed similar cycle ergometry testing 
in trained and untrained participants respectively.  Despite workload differences between 
protocols, Amann et al. (2004), Bentley et al. (2003) and Foster et al. (1999) also found that 
length of stage duration had no bearing upon the final results, suggesting &VO2max is largely the 
same during incremental graded exercise cycling regardless of the rate of work increase.  Our 
findings are in direct contrast to those of Buchfuhrer et al. (1983), McLellan (1985) and 
Froelicher et al. (1974), whose studies indicated that longer tests with stage lengths of greater 
than 60 secs duration could result in ventilatory musculature fatigue and an increased 
thermoregulatory load; both of which contribute to lower the average &VO2max value when test 
length exceeds 10 mins.  
 
Due to the research design of the current study, time to achieve maximal &VO2 uptake was 
directly related to the length of stage duration.  As a consequence, the time differential had a 
follow-on effect, with the faster rates of work increase in the SS and CL+SS protocols resulting 
in significantly higher Wmax values.  The &VO2max versus Wmax relationship for the three 
protocols is shown in Figure 1.  The disparity between linear trendlines indicates the 
physiological response to the workload imposed in the LS protocol was of a much higher energy 
magnitude than that posed in SS and CL+SS.  That is, the 3-min stage durations in the LS 
protocol resulted in significantly lower Wmax values compared to the SS and CL+SS protocols, 
despite no significant difference in &VO2max.  Similar findings have been reported previously 
(Bentley et al., 2003; Bishop et al., 1998).  The similarity in &VO2max values between the three 
protocols appears to indicate that the significant difference in Wmax attributed to stage duration 
variations may have solely influenced the relationship evident between Wmax and &VO2max.  
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This presumption is substantiated by the positive and significant correlation between &VO2max 
and Wmax in the SS and CL+SS protocols, but not in the LS protocol.   
 
The long stage duration protocol in the current study produced a higher HRmax than the two 
shorter duration protocols.  Mean values for the highest HR at each individual workload from 
all ten participants for the three protocols are shown in Figure 2.  Linear trendlines for the HR 
responses to work indicate that when workload increased, the SS and CL+SS protocols were 
almost identical in their HR response, which is expected given that apart from the 4-min 
constant stage at the start of the CL+SS protocol, both protocols increased work in a step-wise 
fashion every min.  The HR responses in the LS protocol were much higher, especially from the 
110W workload onwards, indicating that as the test progressed in duration, 3-min stages 
resulted in a greater cardiovascular effort for the same mechanical work.  There are numerous 
factors that could contribute to the significant elevation in HR.  Prolonged tests such as those 
performed in the LS protocol can produce an increased thermoregulatory load, increased blood 
flow and different substrate use (Buchfuhrer et al., 1983).  It also seems likely that the higher 
HR in the LS protocol compared with the SS and CL+SS protocols can be attributed to 
cardiovascular drift in HR responses that is evident in exercise testing that exceeds 10-15 mins 
(Coyle, 1998; Rowell, 1974). 
 
In contrast, the long protocol in this study was responsible for producing significantly lower 
respiratory exchange ratios than the shorter duration protocols.  An inclination towards lower 
RERmax in more prolonged incremental graded exercise tests has been reported previously 
(Lukaski et al., 1989), and may be due to a depletion in bicarbonate reserves caused by 
spending an increased amount of time working above VT before reaching &VO2max.  The 
comparatively higher RERmax in the SS and CL+SS protocols is most likely attributable to 
higher concentrations of non-metabolic &VCO2 resulting from the buffering of lactic acid 
(McArdle et al., 2001).  Whether this culminated in some participants producing hyper-
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ventilatory responses during the shorter stage duration protocols is unclear.  It should be noted 
that data from this study and that of Pierce et al. (1999) and Bentley et al. (2003) suggest the 
use of RER as a criterion for maximal exertion during long stage duration &VO2max tests be 
reassessed as its value may be misrepresented in trained populations.   
 
Despite the plausibility of increased rates of lactic acid buffering causing the significance of 
difference in RERmax, there was no significant difference in BLamax values obtained at the 
end of each trial.  Combined with a similarity in RPEmax ratings, it would appear there was no 
disparity in the level of musculature fatigue or physical exertion between the protocols.  A 
comparison of physiological variables at the point of VT shows the only significant difference 
between short and long stage duration protocols was the time and workload at which VT 
occurred, and the associated HR response.  Even with the lack of statistical difference in &VO2, 
the 3-min stage durations in the LS protocol were directly responsible for elevating HR at VT 
compared to that evident in the SS and CL+SS protocols.  All other variables including &VO2, 
RER and % &VO2max were not different, demonstrating VT can be accurately determined from a 
test involving either 1-min or 3-min stage duration increments.  Further, as &VO2max was not 
significantly different between protocols, it is possible to conclude that short or long stage 
durations are appropriate for &VO2max determination in incremental graded cycle ergometry 
protocols.   
 
To ensure that the data used for prescription of exercise is truly representative of aerobic power, 
it is necessary to have confidence in the &VO2max measurement upon which it is based, 
regardless of the protocol employed.  Hence the need to assess the agreement and repeatability 
of results from graded exercise tests on a trial-to-trial basis.  Statistics from Bland-Altman 
analysis indicate that a slight systematic variation was evident between trials for the SS and 
CL+SS protocols.  However, given there were no significant differences in physiological 
variables nor the numbers of threshold criteria met, it can be concluded that there was excellent 
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repeatability and high levels of agreement between trial 1 and trial 2 for the SS and CL+SS 
protocols.  Therefore, should either of these protocols be selected for use in a research or testing 
situation, it is possible that the performance of only one trial will suffice for accurate and 
reproducible &VO2max determination.  Conversely, significant differences in time to maximum, 
Wmax and &VO2max were apparent between trial 1 and trial 2 for the LS protocol.  There was 
also a minor systematic variation between trials for this longer stage duration protocol, with 
Bland-Altman analysis showing a bias towards higher results obtained in trial 1 compared to 
trial 2.  It is difficult to identify the exact reason for the divergence between trials, but carry-
over fatigue due to the nature of the testing schedule may be responsible for a decline in 
performance. This would explain the decrease in Wmax and the subsequent drop in &VO2max 
from trial 1 to trial 2.  Accordingly, despite the fact that no significant differences were reported 
in the number of threshold criteria attained between trial 1 and trial 2, it would appear necessary 
that a number of trials be performed when using protocols similar to LS to obtain the most 
accurate and repeatable &VO2max possible. 
 
At this point it is important to note that incorporating a 4-min constant workload at the start of 
the CL+SS protocol had no detrimental impact upon &VO2max compared to the incremental only 
SS and LS protocols.  As the acquisition of steady state data can be useful when assessing 
exercise efficiency and its change over time, especially during the course of a training program, 
it may be beneficial to employ protocols similar to the CL+SS protocol in order to get as much 
data from one test as possible.  However, given the low workload of 50W, it is unlikely that one 
could deduce much practical information about exercise efficiency when utilising the CL+SS 
protocol in its current format in a highly trained cohort.  Consequently, the applicability of the 
CL+SS protocol lies more so in a clinical environment testing untrained and/or overweight 
individuals.   
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When directly assessing the impact of exercise mode on exercise capacity, it is well accepted 
that there will be significant differences in physiological responses between ergometers if the 
protocol remains unchanged (McArdle et al., 1973; Maeder et al., 2005).  However, evidence 
available within the literature suggests that when using the same exercise modality but different 
exercise test protocols, there will be no effect of exercise mode.  For instance, Pierce et al. 
(1999) showed that in 11 highly-trained rowers, discontinuous protocols involving seven stages 
of 3-4 mins duration (total test time of 21-28 mins) can provide &VO2max measurements similar 
to those that averaged 12 mins ± 4 secs duration.  Moreover, in a study of eight well-trained 
runners, Kuipers et al. (2003) found that mean &VO2max was not significantly different between 
three protocols conducted with 1-, 3- and 6-min stage durations.  Even though it is clear more 
research is required to conclude with certainty, based upon the results from the above-
mentioned studies which employed similar methodologies, it appears as though the results from 
the current study are independent of the mode of exercise.   
 
In addition to assessing the impact of exercise modality, it is also valuable to identify the 
applicability of the data from the current study in the relation to other populations; in this case, 
highly trained athletes.  In a study by Amann et al. (2004), 15 trained male cyclists performed 
two incremental cycle ergometry exercise tests of different stage duration length.  Results 
showed that despite a difference in Wmax (363W vs 402W; P<0.01), &VO2max was similar 
between the two protocols (66.6 ± 5.6 ml·kg-1·min-1 vs 67.6 ± 5.3 ml·kg-1·min-1).  Bentley and 
McNaughton (2003) had similar findings in their study of nine well trained tri-athletes who 
performed one short and long stage duration protocol, reporting that there was no significant 
difference in &VO2max (62.8 ± 4.7 ml·kg-1·min-1 vs 61.6 ± 5.8 ml·kg-1·min-1), even though there 
was a significant difference in Wmax (424W vs 355W; P<0.01).  Although research conducted 
using highly trained athletes has obtained a similar trend of results to those presented in the 
current study, the workload increments and associated Wmax values were different.  Hence, 
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more research is required to definitively conclude if the results from the current study can be 
extrapolated to highly trained individuals.  
 
Once &VO2max has been determined and the repeatability between trials clearly established, 
suitable utilisation of the data becomes important.  While the influence of stage duration upon 
&VO2max has been assessed previously, the impact upon exercise prescription parameters has 
not been widely discussed.  Findings from the current study indicate that when prescribing a 
chosen exercise intensity using the standardised percentage &VO2max method, data from short or 
long stage duration protocols may be used as the lack of difference in &VO2max between the SS, 
LS and CL+SS protocols would result in similar mechanical workloads being prescribed.  
However, some methods of exercise prescription may be based around Wmax and HRmax 
rather than percentage &VO2max and in this instance, the impact of stage duration upon exercise 
prescription parameters is much more substantial.  Wmax was significantly different between 
the SS and LS protocols as well as the LS and CL+SS protocols, despite their similarities in 
&VO2max.  Mean linear trendlines in Figures 2 and 3 show HR and &VO2 responses in the LS 
protocol were increased from the 110W workload onwards compared to the SS and CL+SS 
protocols.  What these findings suggest is that the physiological responses during the 3-min 
stages in the LS protocol were of higher metabolic cost than for the same workload during 1-
min stages in the SS and CL+SS protocols.  If set an exercise program intensity of 75% Wmax 
or HRmax, an individual will be working at a much higher relative HR and &VO2 or workload 
and &VO2 respectively if the prescription is based on data garnered from the LS protocols as 
compared to the SS and CL+SS protocols.  Hence, due diligence should be observed when 
prescribing exercise using data from long stage duration protocols as a discrepancy will be 
apparent in mechanical and physiological work compared to shorter stage duration protocols.          
 
In conclusion, the current study has shown that when stage durations of either 1-min or 3-mins 
during an incremental graded cycle ergometry protocol are compared in a group of 
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recreationally-trained males, &VO2max does not differ significantly.  Also, the short stage 
duration protocols (SS and CL+SS) were shown to produce highly repeatable results, potentially 
allowing for a reduction in the number of tests performed.  Finally, depending upon the method 
of exercise prescription employed the disparity in HRmax and Wmax between the short and 
long stage duration protocols could translate into a considerable difference in mechanical and 
physiological work undertaken.  Noting the differences in responses is therefore important as it 
could mean individuals work at a higher energy cost than necessary.  Choosing one &VO2max 
testing protocol and keeping it consistent may alleviate any potential errors during the testing to 
prescription transition. 
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TABLES 
 
Table 1. Descriptive data of participants [n = 10] presented as mean ± SD and (range). 
Age (yrs) Body Mass (kg) Height (cm) BMI (kg·m-2) 
27.8 ± 7.1 
(20.0 – 40.0) 
77.8 ± 8.1 
(67.8 – 88.5) 
182.1 ± 5.2 
(175.5 – 190.0) 
24.3 ± 2.5 
(21.2 – 27.6) 
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Table 2. Correlation coefficients (r and P values) relating to the comparison of physiological 
variables between trial 1 and trial 2 for the SS, LS and CL+SS protocols. 
 
 SS LS CL+SS 
 r P r P r P 
Time to max 
(mins) 
0.97 <0.0001 0.98 <0.0001 0.96 <0.0001 
Wmax 
(watts) 
0.97 <0.0001 0.98 <0.0001 0.96 <0.0001 
VO2max 
(l·min-1) 
0.94 <0.0001 0.95 <0.0001 0.92 <0.0001 
VO2max 
(ml·kg-1·min-1) 
0.86 <0.005 0.92 <0.0001 0.83 <0.005 
HRmax 
(bt·min-1) 
0.85 <0.005 0.94 <0.0001 0.78 <0.005 
RERmax 0.68 <0.05 0.64 <0.05 0.53 NS 
BLamax 
(mmol·l-1) 
0.45 NS 0.81 <0.005 0.63 <0.05 
RPEmax 0.61 NS · · * 0.22 NS 
 
* Correlation cannot be computed as the RPEmax values during trial 1 of the LS protocol were constant 
(ie. all participants rated their exertion as ‘20’ at the end of the trial 1 for the LS protocol). 
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Table 3. Bland-Altman statistics relating to the comparison of physiological variables between 
trial 1 and trial 2 for the SS, LS and CL+SS protocols.  ULA = 95% upper limit of agreement; 
LLA = 95% lower limit of agreement.  
 
  SS   LS   CL+SS  
 Bias ULA LLA Bias ULA LLA Bias ULA LLA 
Time to max 
(mins) 
-0.10 
 
0.80 
 
-1.00 
 
1.05 
 
2.98 
 
-0.88 
 
0.20 
 
1.15 
 
-0.75 
 
Wmax 
(watts) 
-3.00 
 
24.02 
 
-30.02 
 
10.50 
 
29.80 
 
-8.80 
 
6.00 
 
34.40 
 
-22.40 
 
VO2max 
(l·min-1) 
-0.12 
 
0.41 
 
-0.65 
 
0.16 
 
0.48 
 
-0.16 
 
0.08 
 
0.49 
 
-0.32 
 
VO2max 
(ml·kg-1·min-1) 
-1.39 
 
5.51 
 
-8.28 
 
2.41 
 
6.22 
 
-1.40 
 
1.09 
 
6.48 
 
-4.31 
 
HRmax 
(bt·min-1) 
-1.48 
 
8.74 
 
-11.71 
 
1.83 
 
8.18 
 
-4.52 
 
3.43 
 
14.63 
 
-7.76 
 
RERmax -0.01 
 
0.09 
 
-0.10 
 
0.00 
 
0.04 
 
-0.03 
 
0.02 
 
0.13 
 
-0.10 
 
BLamax 
(mmol·l-1) 
-0.75 
 
3.78 
 
-5.28 
 
0.36 
 
4.44 
 
-3.72 
 
-0.22 
 
3.99 
 
-4.44 
 
RPEmax -0.20 
 
0.63 
 
-1.03 
 
0.20 
 
1.03 
 
-0.63 
 
-0.10 
 
1.01 
 
-1.21 
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Table 4. Comparison of physiological variables (mean ± SD) between trial 1 and trial 2 for the 
SS, LS and CL+SS protocols.  
 
  SS   LS   CL+SS 
 Trial 1 Trial 2 P Trial 1 Trial 2 P Trial 1 Trial 2 P
Time to max 
(mins) 
10.25 ± 1.5 10.35 ± 1.7 NS 25.45 ± 3.98 24.40 ± 4.37 <0.01 13.5 ± 1.75 13.3 ± 1.58 N
Wmax 
(watts) 
327.5 ± 44.86 330.5 ± 51.01 NS 275.5 ± 39.75 265.0 ± 43.97 <0.01 335.0 ± 52.44 329.0  ± 47.54 N
VO2max 
(l·min-1) 
3.9 ± 0.45 4.02 ± 0.65 NS 4.02 ± 0.41 3.86 ± 0.49 <0.05 3.96 ± 0.52 3.87 ± 0.51 N
VO2max 
(ml·kg-1·min-1) 
50.21 ± 4.48 51.6 ± 6.48 NS 51.76 ± 4.1 49.34 ± 4.83 <0.01 50.85 ± 4.88 49.77 ± 4.47 N
HRmax 
(bt·min-1) 
179.5 ± 8.51 180.98 ± 9.84 NS 185.33 ± 8.92 183.50 ± 9.48 NS 181.90 ± 9.03 178.47 ± 8.02 N
RERmax 1.22 ± 0.07 1.23 ± 0.05 NS 1.12 ± 0.02 1.11 ±  0.03 NS 1.26 ± 0.06 1.24 ± 0.06 N
BLamax 
(mmol·l-1) 
11.76 ± 2.23 12.52 ± 2.18 NS 11.87 ± 3.53 11.51 ±  2.7 NS 11.98 ± 2.38 12.21 ± 2.62 N
RPEmax 
 
19.6 ± 0.52 19.8 ± 0.42 NS 20.0 ± 0.0 19.8 ± 0.42 NS 19.7 ± 0.48 19.8 ± 0.42 N
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Table 5. Comparison of physiological variables (combined results from trial 1 and trial 2; mean 
± SD) between the SS, LS and CL+SS protocols.  
 
 SS LS CL+SS (SS v LS) 
P  
(SS v CL+SS) 
P 
(LS v CL+SS) 
P  
Time to max 
(mins) 
10.3 ± 1.56 24.93 ± 4.1 13.40 ± 1.63 <0.0001 <0.0001 <0.0001 
Wmax 
(watts) 
329.0 ± 46.78 270.25 ± 41.15 332.0 ± 48.81 <0.0001 NS <0.0001 
VO2max 
(l·min-1) 
3.96 ± 0.54 3.94 ± 0.44 3.92 ± 0.51 NS NS NS 
VO2max 
(ml·kg-1·min-1) 
50.90 ± 5.47 50.55 ± 4.53 50.31 ± 4.59 NS NS NS 
HRmax 
(bt·min-1) 
180.24 ± 8.99 184.42 ± 9.01 180.18 ± 8.5 <0.05 NS <0.05 
RERmax 1.23 ± 0.06 1.12 ± 0.02 1.25 ± 0.06 <0.0001 <0.05 <0.0001 
BLamax 
(mmol·l-1) 
12.14 ± 2.18 11.69 ± 3.07 12.10 ± 2.44 NS NS NS 
RPEmax 
 
19.7 ± 0.47 19.9 ± 0.31 19.8 ± 0.44 NS NS NS 
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FIGURE LEGEND 
 
This figure legend relates to Figures 1, 2 and 3 presented below. 
 
 
SS 
LS 
CL+SS 
Linear (SS) 
Linear (LS) 
Linear (CL+SS) 
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FIGURES 
 
Figure 1. Relationship between mechanical (Wmax) and physiological ( &VO2max) responses at 
the point of &VO2max during the three protocols.  Responses shown are the averages of trial 1 
and trial 2 for the 10 participants. 
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Figure 2. Highest average HR responses at each individual during the three protocols.  
Responses shown are the averages of trial 1 and trial 2 for the 10 participants. 
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Figure 3. Highest average &VO2 responses at each individual workload during the three 
protocols.  Responses shown are the averages of trial 1 and trial 2 for the 10 participants. 
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